"While there are many drugs used to treat type 2 diabetes (sulfonylureas, DPP-4 inhibitors, SGLT-2 inhibitors, TZDs, GLP-1 agonists, etc.), these results may make Jardiance or other SGLT-2 inhibitors the standard second-line therapy (after metformin) used to treat type 2 diabetes (or potentially first-line therapy if the magnitude is really meaningful we wont know anything about that for a month, when the specifics on the results are disclosed)
Diabetes patients (Type 1, Type 2, Gestational) Endocrinology clinics Home health nurses Pharmacies and hospitals Caregivers and family members Why Choose Easy Touch U-100 Insulin Syringes
Analyses used SAS version 9.3 mixed-effects regression models to estimate the effect and effect size of the treatment (Laird and Ware, a priori hypothesis that the change in the metabolic biomarker was greater for participants who underwent treatment as compared with the placebo group
The pathological formation of IA is influenced by complex interactions between genetic and environmental risk factors such as congenital dysgenesis and acquired atherosclerosis of the cerebral arteries (Zhong et al., 2021)
GLP-1 appears to attenuate the process of neuroinflammation and protects neurons and glia under oxidative stress conditions in the depressive brain
10.1016/j.psj.2021.101622 86
